The FDA will decide whether to uphold, revise or scrap longstanding restrictions on the abortion drug mifepristone. This decision will likely kick off the next chapter in the abortion wars.
The FDA will decide whether to uphold, revise or scrap longstanding restrictions on the abortion drug mifepristone. This decision will likely kick off the next chapter in the abortion wars.